These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 12089993

  • 21. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M, Gerth J, Ott U, Schip A, Haufe CC, Gröne HJ, Wolf G.
    Med Klin (Munich); 2008 Jul 15; 103(7):519-24. PubMed ID: 18604487
    [Abstract] [Full Text] [Related]

  • 22. Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
    Papasotiriou M, Kalliakmani P, Huang L, Gerolymos M, Goumenos DS, Johnson TS.
    Nephron Clin Pract; 2012 Jul 15; 121(1-2):c60-7. PubMed ID: 23107829
    [Abstract] [Full Text] [Related]

  • 23. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
    Kanigicherla DAK, Hamilton P, Czapla K, Brenchley PE.
    Nephrology (Carlton); 2018 Jan 15; 23(1):60-68. PubMed ID: 27778424
    [Abstract] [Full Text] [Related]

  • 24. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.
    Javaugue V, Karras A, Glowacki F, McGregor B, Lacombe C, Goujon JM, Ragot S, Aucouturier P, Touchard G, Bridoux F.
    Am J Kidney Dis; 2013 Oct 15; 62(4):679-90. PubMed ID: 23759297
    [Abstract] [Full Text] [Related]

  • 25. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2006 Feb 15; 21(2):389-96. PubMed ID: 16234291
    [Abstract] [Full Text] [Related]

  • 26. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Feb 15; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 27. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
    Cortazar FB, Leaf DE, Owens CT, Laliberte K, Pendergraft WF, Niles JL.
    BMC Nephrol; 2017 Feb 01; 18(1):44. PubMed ID: 28143416
    [Abstract] [Full Text] [Related]

  • 28. Idiopathic membranous nephropathy and nephrotic syndrome: outcome in the era of evidence-based therapy.
    McQuarrie EP, Stirling CM, Geddes CC.
    Nephrol Dial Transplant; 2012 Jan 01; 27(1):235-42. PubMed ID: 21558430
    [Abstract] [Full Text] [Related]

  • 29. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
    Jha V, Ganguli A, Saha TK, Kohli HS, Sud K, Gupta KL, Joshi K, Sakhuja V.
    J Am Soc Nephrol; 2007 Jun 01; 18(6):1899-904. PubMed ID: 17494881
    [Abstract] [Full Text] [Related]

  • 30. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K, Tapaneya-Olarn C, Tapaneya-Olarn W.
    J Med Assoc Thai; 1999 Nov 01; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [Abstract] [Full Text] [Related]

  • 31. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
    Laluck BJ, Cattran DC.
    Am J Kidney Dis; 1999 Jun 01; 33(6):1026-32. PubMed ID: 10352189
    [Abstract] [Full Text] [Related]

  • 32. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
    Rutkowski B, Wielgosz A, Manitius J, Bułło B, Kowalewska J, Tylicki L, Roszkiewicz A.
    Przegl Lek; 2000 Jun 01; 57(11):624-7. PubMed ID: 11293209
    [Abstract] [Full Text] [Related]

  • 33. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H, Ribes D, Modesto A, Kamar N, Durand D, Rostaing L.
    Nephrol Ther; 2007 Apr 01; 3(2):65-8. PubMed ID: 17452303
    [Abstract] [Full Text] [Related]

  • 34. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C, Passerini P, Salvadori M, Manno C, Viola BF, Pasquali S, Mandolfo S, Messa P.
    Am J Kidney Dis; 2006 Feb 01; 47(2):233-40. PubMed ID: 16431252
    [Abstract] [Full Text] [Related]

  • 35. Sustained remission of membranous glomerulonephritis after cyclophosphamide and prednisone.
    Bruns FJ, Adler S, Fraley DS, Segel DP.
    Ann Intern Med; 1991 May 01; 114(9):725-30. PubMed ID: 2012353
    [Abstract] [Full Text] [Related]

  • 36. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH, Grcevska L.
    Am J Kidney Dis; 1999 Nov 01; 34(5):911-7. PubMed ID: 10561149
    [Abstract] [Full Text] [Related]

  • 37. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Nov 01; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 38. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P, Pasquali S, Cesana B, Zucchelli P, Ponticelli C.
    Nephrol Dial Transplant; 1989 Nov 01; 4(6):525-9. PubMed ID: 2507973
    [Abstract] [Full Text] [Related]

  • 39. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec 01; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 40. Membranous glomerulonephritis: treatment response and outcome in children.
    Valentini RP, Mattoo TK, Kapur G, Imam A.
    Pediatr Nephrol; 2009 Feb 01; 24(2):301-8. PubMed ID: 18846392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.